Products for Research Use Only
RegisterLogin

Tandutinib (MLN518)

CAT: 0607-B1526-100Size: 100 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0607-B1526-100Size:100 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
FLT3 inhibitor,potent and selective
CAS Number
387867-13-2
Product Name Alternative
4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide
Field of Research
Tyrosine Kinase FLT3
Purity
0.98
Form
A solid
Solubility
≥17.85 mg/mL in DMSO
Smiles
CC(C)OC1=CC=C(C=C1)NC(=O)N2CCN(CC2)C3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCCC5
Molecular Formula
C31H42N6O4
Molecular Weight
562.72
Shipping Conditions
Blue ice
Storage Conditions
Store at -20°C.

Chemical Information

Tandutinib

Tandutinib is an N-arylpiperazine that is piperazine in which the hydrogen attached to the nitrogen at position 1 is replaced by a 6-methoxy-7-[3-(piperidin-1-yl)propoxy]quinazolin-4-yl group, while the hydrogen attached to the nitrogen at position 4 is replaced by a (p-isopropoxyphenyl)aminocarbonyl group. Tandutinib is an inhibitor of tyrosine kinases FLT3, PDGFR and KIT. It has a role as an antineoplastic agent and an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor. It is a member of phenylureas, a member of piperidines, an aromatic ether, a member of quinazolines, a N-arylpiperazine, a N-carbamoylpiperazine and a tertiary amino compound.

CAS Number387867-13-2
PubChem CID3038522
IUPAC Name4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide
Molecular FormulaC31H42N6O4
Molecular Weight562.7
XLogP4.6
Topological Polar Surface Area92.3
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count8
Rotatable Bond Count10
Heavy Atom Count41
Formal Charge0
Complexity783
SMILES
CC(C)OC1=CC=C(C=C1)NC(=O)N2CCN(CC2)C3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCCC5
InChI
InChI=1S/C31H42N6O4/c1-23(2)41-25-10-8-24(9-11-25)34-31(38)37-17-15-36(16-18-37)30-26-20-28(39-3)29(21-27(26)32-22-33-30)40-19-7-14-35-12-5-4-6-13-35/h8-11,20-23H,4-7,12-19H2,1-3H3,(H,34,38)
InChIKey
UXXQOJXBIDBUAC-UHFFFAOYSA-N
Chemical Structure
2D Structure
2D structure of Tandutinib
CAS: 387867-13-2
CID: 3038522
Formula: C31H42N6O4
MW: 562.7
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight562.7
XLogP34.6
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count8
Rotatable Bond Count10
Exact Mass562.32675384
Monoisotopic Mass562.32675384
Topological Polar Surface Area92.3 Ų
Heavy Atom Count41
Formal Charge0
Complexity783
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Related Products

CatalogName
A8551-5INK 128 (MLN0128)
A8551-50INK 128 (MLN0128)
A8551-10INK 128 (MLN0128)
A8551-5.1INK 128 (MLN0128)

Alternative Products

CatalogName
E1KS1043Tandutinib (mLN518)
T23418-01Tandutinib (MLN518) HCl
A10887-10mM-DTandutinib (MLN518) 10mM * 1mL in DMSO
T0895-50Tandutinib, Free Base (4-[6-methoxy-7-[3- (1-piperidinyl) propoxy]-4-quinazolinyl]-N-[4- (1-methylethoxy) phenyl]-1-piperazinecarboxamide, MLN518, CT53518, D06005)
MBS655350-01Tandutinib, Free Base (4-[6-methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl]-N-[4-(1-methylethoxy)phenyl]-1-piperazinecarboxamide, MLN518, CT53518, D06005)
FT28001Tandutinib

Popular Products